Clinical Trials Directory

Trials / Terminated

TerminatedNCT02407626

Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery

Optimierung Der Kardioprotektion Durch Inhalative Anästhetika Eine Untersuchung Bei Patienten Mit Diabetes Mellitus während Off-pump Herzchirurgie

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Triemli Hospital · Academic / Other
Sex
Male
Age
40 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the myocardial protection against perioperative ischemia comparing two standard anesthetic regimes in diabetic patients undergoing elective cardiac surgery. Half of the patients will receive volatile anesthesia while the other half will receive total intravenous anesthesia. Primary and secondary outcome parameters will be assessed after induction of anesthesia, at the end of the procedure and postoperative day 1 to 3.

Detailed description

Volatile anaesthetics such as Sevoflurane have shown to have a protective effect regarding myocardial ischemia in the perioperative setting - the so-called "preconditioning". However the observed response of preconditioning in clinical trials is not consistent. An increased perioperative insulin resistance especially in diabetic patients resulting in an increased postoperative morbidity and mortality may be responsible for these findings. In an animal model, the use of propofol that is being routinely applied for general anesthesia was associated with a change of the insulin receptor substrate via phosphorylation and thus a change of insulin resistance. Avoiding a total intravenous anesthesia and applying a volatile anesthesia may result in an increased cardioprotective effect by a reduction of the perioperative insulin resistance.

Conditions

Interventions

TypeNameDescription
DRUGPropofolTotal intravenous anesthesia is a clinical standard procedure
DRUGSevofluraneVolatile anesthesia is a clinical standard procedure

Timeline

Start date
2015-09-01
Primary completion
2018-03-07
Completion
2018-03-07
First posted
2015-04-03
Last updated
2018-03-09

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02407626. Inclusion in this directory is not an endorsement.